Teligent Pharma, Inc. recalls Halobetasol Propionate Ointment, 0.05%, packaged as a) 15 g tubes, NDC 52565-073-15; b) 50 g tubes, NDC 52565-073-51, Rx
Recalled March 30, 2022 · FDA recall D-0689-2022 · Teligent Pharma
Hazard
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program. · FDA Class II
Units
161,331 tubes
Sold at
Nationwide in the USA and Puerto Rico
Description
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Product
Halobetasol Propionate Ointment, 0.05%, packaged as a) 15 g tubes, NDC 52565-073-15; b) 50 g tubes, NDC 52565-073-51, Rx Only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.
Manufacturer(s)
Teligent Pharma, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →